Home › Epilepsy › New Jersey
Epilepsy clinical trials in New Jersey
5 studies for Epilepsy are looking for participants at sites in New Jersey.
Cities in New Jersey
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Northeast Regional Epilepsy Group, Hackensack
- Institute of Neurology and Neurosurgery at St. Barnabas, Livingston
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT07563881A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Northeast Regional Epilepsy Group, Hackensack
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 2, 2026 · NCT05667142A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Northeast Regional Epilepsy Group, Hackensack
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT05716100Post-Market Real-World Evidence Registry for the NeuroOne OneRF® Ablation System for Epilepsy
- Cooperman Barnabas Medical Center - 94 Old Short Hills Rd, Livingston
- Robert Wood Johnson University Hospital - 1 Robert Wood Johnson Pl, New Brunswick
RecruitingObservational study
All ages · All sexes · Updated Oct 16, 2026 · NCT07546253AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
- Northeast Regional Epilepsy Group, Hackensack
- Robert Wood Johnson Hospital, New Brunswick
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Aug 24, 2026 · NCT06063850From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.